[artículo] 
inEuropean Neuropsychopharmacology > Año 2014 - Vol. 24 - No.6 (Junio) . - pp. 846-855

Título :	Intranasal desmopressin as an adjunct to risperidone for negative symptoms of schizophrenia : A randomized, double-blind, placebo-controlled, clinical trial
Tipo de documento:	texto impreso
Autores:	Seyed Mohammad Reza Hosseini, Autor ; Mehdi Farokhnia, Autor ; Farzin Rezaei, Autor
Fecha de publicación:	2021
Artículo en la página:	pp. 846-855
Idioma :	Inglés (eng) Idioma original : Inglés (eng)
Palabras clave:	Desmopresina, DDAVP, Síntomas negativos, Esquizofrenia, Vasopresina
Resumen:	Considering the role of neurohypophyseal peptides in normal development and function of higher cortical processes along with their proven abnormalities in schizophrenic patients, these pathways have recently attracted greater attention as treatment targets for schizophrenia.
Link:	./index.php?lvl=notice_display&id=27000

[artículo] Intranasal desmopressin as an adjunct to risperidone for negative symptoms of schizophrenia : A randomized, double-blind, placebo-controlled, clinical trial [texto impreso] / Seyed Mohammad Reza Hosseini, Autor ; Mehdi Farokhnia, Autor ; Farzin Rezaei, Autor . - 2021 . - pp. 846-855.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in European Neuropsychopharmacology > Año 2014 - Vol. 24 - No.6 (Junio) . - pp. 846-855

Palabras clave:	Desmopresina, DDAVP, Síntomas negativos, Esquizofrenia, Vasopresina
Resumen:	Considering the role of neurohypophyseal peptides in normal development and function of higher cortical processes along with their proven abnormalities in schizophrenic patients, these pathways have recently attracted greater attention as treatment targets for schizophrenia.
Link:	./index.php?lvl=notice_display&id=27000